Guillain-Barré Syndrome Linked to the RSV Vaccine
The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]
Taiwan Compensates Family of Girl Who Died Days After Getting Second Dose of Pfizer’s COVID Shot
The Ministry of Health and Welfare of Taiwan has agreed to pay $114,829 under the National Vaccine Injury Compensation Program (VICP) to the family of a young girl in Taoyuan, Taiwan, who died of myocarditis (inflammation of the heart muscle) within days of receiving the second dose of Pfizer/BioNTech’s Comirnaty COVID-19 messenger RNA (mRNA) shot. […]
CDC Adds COVID Shots to Recommended Vaccine Schedules for Children and Adults
The U.S. Centers for Disease Control and Prevention (CDC) has updated recommended vaccine schedules for children, adolescents and adults to include the COVID-19 biologics. The move is consistent with recommendations made by the agency’s Advisory Committee on Vaccine Practices (ACIP) in October 2022.1 2 3 4 5 The update of the recommended vaccination schedules was […]
Natural Immunity Wins Again
A new study in The Lancet has confirmed that natural immunity from COVID infection is at least as protective and durable against severe complications as vaccination. Yet again, another COVID “conspiracy theory” has become today’s “The Science™.” Natural immunity has long been a well known and accepted part of immunology, despite rabid, frenzied attempts to discredit it. Anthony […]
Study Shows mRNA Can Persist in the Body Up to 28 Days
A new study from Denmark shows that the messenger RNA (mRNA) genetic material, which instructs the body’s cells to make the SAR-CoV-2 spike protein, can be found in the blood as long as 28 days after vaccination with Pfizer/BioNTech’s Comirnaty or Moderna/NIAID Spikevax mRNA COVID1-9 biologics. These findings stand in direct contrast to claims by […]
Government Buys 1.5 Million More Doses of Novavax’s COVID Vaccine
Biotechnology company Novavax announced that it has made a modification to an existing contract with the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DoD) to provide up to 1.5 million more doses of its Nuvaxovid COVID-19 vaccine (also known as “NVX-CoV2373” and “Covovax”), in addition to the 3.2 million […]